1. Home
  2. FISV vs RMD Comparison

FISV vs RMD Comparison

Compare FISV & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiserv Inc.

FISV

Fiserv Inc.

N/A

Current Price

$58.12

Market Cap

34.1B

Sector

Real Estate

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$228.83

Market Cap

33.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FISV
RMD
Founded
1984
1989
Country
United States
United States
Employees
38000
10600
Industry
Real Estate
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.1B
33.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FISV
RMD
Price
$58.12
$228.83
Analyst Decision
Buy
Buy
Analyst Count
28
10
Target Price
$146.17
$293.70
AVG Volume (30 Days)
5.7M
859.0K
Earning Date
04-23-2026
04-22-2026
Dividend Yield
N/A
1.06%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.64
Revenue Next Year
$3.92
$7.38
P/E Ratio
$9.94
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$55.87
$199.92
52 Week High
$70.41
$293.81

Technical Indicators

Market Signals
Indicator
FISV
RMD
Relative Strength Index (RSI) 43.79 32.77
Support Level $57.85 N/A
Resistance Level $64.46 $260.21
Average True Range (ATR) 1.58 4.81
MACD -0.15 -1.92
Stochastic Oscillator 26.52 11.58

Price Performance

Historical Comparison
FISV
RMD

About FISV Fiserv Inc.

Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: